PulteGroup Heads Into Earnings with Shorts Retreating and Options Turning Defensive

Options tell the opposite story. The put/call ratio is running at 1.32, a full standard deviation above its 20-day average of 1.16 and the highest sustained level since at least late August. That cluster of defensive positioning has held firm for two consecutive weeks: the PCR has not dipped below 1.30 since September 28, a stark contrast to the sub-1.0 readings that prevailed through August and early September. At its 52-week high the PCR hit 1.50, so the current level is elevated but not extreme. Still, options traders are paying notably more for downside protection than they were a month ago, even as short sellers are heading for the exit.

The Street has been busy trimming targets ahead of the print, though it has not abandoned the bull case. Barclays cut its price target to $110 from $124 on October 6, keeping an Equal-Weight rating. That move is notable because it places Barclays' target below the current share price of $116. Morgan Stanley initiated coverage at Equal-Weight with a $128 target just last week. Evercore ISI, Truist, and Wells Fargo all lowered targets in September but maintained positive ratings, keeping the consensus in constructive territory with a mean target of $138. The gap between that consensus target and the current price implies around 19% upside on paper. Bulls point to PulteGroup's 10-year sales CAGR near 10%, a 15% return on equity, and a buyer mix tilted toward move-up and active-adult purchasers who are less sensitive to rate moves than entry-level buyers. Bears counter that Q2 revenue fell 10% year over year to $4.0 billion, closings were down 8%, and gross margin compressed to 25% from 27% a year earlier as incentive costs rose. The PE multiple near 10.8x and EV/EBITDA near 7.9x are modest, but the factor scores reflect the ambiguity: EPS surprise ranks at the 71st percentile, a decent track record of beating, while the 30-day EPS momentum score sits at just the 24th percentile, pointing to recent estimate cuts.

The stock is down 7% over the past month to $116.10, a sharper pullback than most homebuilder peers. DHI lost roughly 2% on the week and TOL gained 1.6%, while LEN fell nearly 7%, suggesting the sector is broadly under pressure from rate and affordability concerns rather than PHM-specific news. The two most recent earnings reactions on record show divergent outcomes: July's Q2 print produced just a 0.3% day-one move but a 6.5% gain over the following five days, while the April print saw a 2% drop on the day and a 3.9% loss over five days. The pattern is not consistent enough to anchor expectations either way.

With thirteen days to the October 20 release, the setup worth watching is whether the options defensive positioning intensifies further or whether the retreating short interest becomes the stronger signal as the print approaches.